2018年3期
Cancer Drug Resistance
- Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses
- Glutamine metabolism in cancer therapy
- Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer
- Molecular bases of Sorcin-dependent resistance to chemotherapeutic agents
- Sphingolipid metabolism and drug resistance in ovarian cancer